Alloy Therapeutics, Inc.

Biotech Waltham, MA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Waltham, MA
Street
275 Second Ave
Zip
02451

Offering

Total offering
$40M
Amount sold
$30M
First sale
Mar 31, 2026
Min investment
$0
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
11

How this filing compares

Ranked #5 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 13.3× the median.

Other Massachusetts filings this week: ALPINE TORTILLA HOLDCO, INC., Base Camp Fund, Base Camp Fund II, BROOKDALE INTERNATIONAL PARTNERS, L.P., Cahaba Partners Core Fixed Income Fund

Leadership

Jason Coloma — Director

Errik B. Anderson — Executive Officer (also: Director)

Logan Snyder — Director

Ulrik Nielsen — Director

Jason Camm — Director

Alex Kolicich — Director

Piotr Bobrowicz — Executive Officer (also: Director)

Anthony Sun — Director

Alaa Halawa — Director

Christian Kanady — Director

Also named on: Echo ATX I, LLC

Filing details

Alloy Therapeutics, Inc. filed a Form D with the SEC on April 15, 2026.

Other newest Biotech companies

Other newest companies in Massachusetts